Endoplasmic reticulum stress in chronic obstructive lung diseases.
1Cystic Fibrosis/Pulmonary Research and Treatment Center, Chapel Hill, NC, USA. carla_ribeiro@med.unc.edu
Airway inflammation in diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) activates the unfolded protein response (UPR). Targeting UPR pathways offers a potential therapeutic strategy for these obstructive airway diseases.
Area of Science:
- Cellular biology
- Respiratory medicine
- Immunology
Background:
- Chronic airway inflammation is a hallmark of diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
- The airway environment in these conditions alters airway epithelia, enhancing their innate defense mechanisms.
- Luminal inflammatory stimuli trigger adaptive changes in human airway epithelia, including endoplasmic reticulum (ER) expansion and increased Ca(2+) stores.
Purpose of the Study:
- To review the connection between airway epithelial inflammation and the activation of the unfolded protein response (UPR).
- To discuss the potential relevance of UPR activation in the context of CF and COPD.
- To explore UPR-targeting as a therapeutic strategy for obstructive airway diseases.
Main Methods:
- Literature review of studies investigating airway inflammation, ER stress, and UPR.
- Analysis of the role of UPR pathways in epithelial adaptation to inflammatory stimuli.
- Examination of UPR activation by triggers like cigarette smoke.
Main Results:
- Epithelial adaptation to inflammation involves ER expansion and Ca(2+) store changes, mediating hyperinflammatory responses.
- Activation of the unfolded protein response (UPR) by ER stress is implicated in these inflammatory processes.
- Cigarette smoke, a key factor in COPD, is known to activate the UPR.
Conclusions:
- UPR activation plays a functional role in airway inflammation.
- Targeting UPR pathways presents a promising therapeutic avenue for obstructive airway diseases like CF and COPD.
- Understanding UPR's role in airway epithelia is crucial for developing new treatments.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

